GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » Institutional Ownership

Kineta (STU:J75) Institutional Ownership : 0.72% (As of Jun. 09, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Kineta Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Kineta's institutional ownership is 0.72%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Kineta's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Kineta's Float Percentage Of Total Shares Outstanding is 74.56%.


Kineta Institutional Ownership Historical Data

The historical data trend for Kineta's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta Institutional Ownership Chart

Kineta Historical Data

The historical data trend for Kineta can be seen below:

2023-07-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 2.96 2.67 2.30 2.31 3.96 5.58 4.87 0.78 0.78 0.72

Kineta Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Kineta (STU:J75) Business Description

Industry
Traded in Other Exchanges
Address
219 Terry Avenue North, Suite 300, Seattle, WA, USA, 98109
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's asset is KVA12.1, a VISTA blocking immunotherapy.

Kineta (STU:J75) Headlines

No Headlines